The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- PMID: 34446261
- DOI: 10.1016/j.rec.2021.07.010
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Erratum in
-
Correction in the article «Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas», Rev Esp Cardiol. 2021;74:790-799.Rev Esp Cardiol (Engl Ed). 2022 Feb;75(2):192. doi: 10.1016/j.rec.2021.10.019. Epub 2021 Dec 23. Rev Esp Cardiol (Engl Ed). 2022. PMID: 34955441 English, Spanish. No abstract available.
Abstract
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. Full English text available from:www.revespcardiol.org/en.
Keywords: Escritura médica; Guía de publicación; Medical writing; Meta-analysis; Metanálisis; Publishing guide; Revisión sistemática; Systematic review.
Copyright © 2021 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous